10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,627 | -133,599 | -97,846 | -59,949 | -255,099 |
| Depreciation Amortization | 43,708 | 35,598 | 22,394 | 11,494 | 43,619 |
| Accounts receivable | 26,951 | 31,321 | 23,638 | 23,516 | -10,613 |
| Accounts payable and accrued liabilities | -3,354 | 10,044 | 5,705 | 4,583 | -6,017 |
| Other Working Capital | 2,338 | 2,630 | -10,362 | -6,297 | 18,021 |
| Other Operating Activity | 119,648 | 67,418 | 48,242 | 10,928 | 194,892 |
| Operating Cash Flow | $6,664 | $13,412 | $-8,229 | $-15,725 | $-15,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,238 | 29,638 | 29,367 | 13,542 | 183,016 |
| PPE Investments | -12,393 | -9,677 | -5,788 | -2,910 | -48,601 |
| Purchase Sale Intangibles | -1,000 | -1,000 | -1,000 | N/A | -923 |
| Other Investing Activity | -1,000 | -1,000 | -1,000 | 0 | -923 |
| Investing Cash Flow | $-32,631 | $18,961 | $22,579 | $10,632 | $133,492 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -5,814 |
| Common Stock Issued | 10,914 | 6,397 | 6,241 | 1,638 | 19,483 |
| Financing Cash Flow | $10,914 | $6,397 | $6,241 | $1,638 | $13,669 |
| Exchange Rate Effect | -164 | 105 | -51 | -48 | -33 |
| Beginning Cash Position | 359,284 | 359,284 | 359,284 | 359,284 | 227,353 |
| End Cash Position | 344,067 | 398,159 | 379,824 | 355,781 | 359,284 |
| Net Cash Flow | $-15,217 | $38,875 | $20,540 | $-3,503 | $131,931 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,664 | 13,412 | -8,229 | -15,725 | -15,197 |
| Capital Expenditure | -12,393 | -9,677 | -5,788 | -2,910 | -48,601 |
| Free Cash Flow | -5,729 | 3,735 | -14,017 | -18,635 | -63,798 |